CLL: Treatment and Management Strategies for Best Outcomes - Episode 9
Yuliya Linhares, MD, discusses the CLL14 study, which is looking at venetoclax plus obinutuzumab in patients with previously untreated chronic lymphocytic leukemia.
Related Content:
What Patients Need to Know About Liver Cancer, From Diagnosis to Treatment
Open Enrollment Made Simple: How to Pick the Best Plan for You
Immunotherapy Advances Transform Small Cell Lung Cancer Care
New Diagnosis Codes Improve Timely Access Inflammatory Breast Cancer Care